Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,087 Dermatology
clinical trials

Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Austin Institute for Clinical Research, Inc. - Central
mi
from
Austin, TX
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Dermatologists of Greater Columbus
mi
from
Bexley, OH
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Diagnostic MRI
mi
from
Houston, TX
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Pace Dermatology Associates
mi
from
Lakewood, WA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Tanenbaum Dermatology Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
ASR, LLC
mi
from
Nampa, ID
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Virginia Dermatology & Skin Cancer Center, Pllc
mi
from
Norfolk, VA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Midwest Allergy Sinus Asthma, SC ( Site 0081)
mi
from
Normal, IL
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Owensboro Dermatology Associates
mi
from
Owensboro, KY
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Mosaic Dermatology
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Dermatology Associates of Seattle
mi
from
Seattle, WA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Tien Q. Nguyen, MD inc. DBA First OC Dermatology
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Olympian Clinical Research
mi
from
Largo, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Acclaim Dermatology
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Progressive Keratoconus Clinical Trial
Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive Keratoconus
Status: Enrolling, Phase III
Updated: 12/31/1969
Minnesota Eye Consultants
mi
from
Minnetonka, MN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Bellaire, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Gahanna, OH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Rockville, MD
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Sandy Springs, GA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Washington DC,
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 501
mi
from
Aventura, FL
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 510
mi
from
Newnan, GA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 222
mi
from
North Miami Beach, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
Status: Enrolling, Phase II
Updated: 12/31/1969
L.A. Universal Research Center, Inc.
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD
Status: Enrolling, Phase IV
Updated: 12/31/1969
Dermatology Trial Associates
mi
from
Bryant, AR
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD
Status: Enrolling, Phase IV
Updated: 12/31/1969
M3-Wake Research, Inc.
mi
from
Raleigh, NC
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 204
mi
from
Fremont, CA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 209
mi
from
Fridley, MN
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 371
mi
from
Saint Joseph, MO
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling, Phase III
Updated: 12/31/1969
Study Site 514
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Laxity; Skin Clinical Trial
Pivotal Study to Evaluate the Effectiveness of a Micro-coring Device Treating Moderate to Severe Facial Wrinkles
Status: Enrolling
Updated: 12/31/1969
The Practice of Brian S. Biesman, M.D
mi
from
Nashville, TN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Tien Q. Nguyen, MD inc. DBA First OC Dermatology
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Olympian Clinical Research
mi
from
Largo, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Acclaim Dermatology
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Aclaris Investigator Site
mi
from
Portland, OR
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Vanda Investigational Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Vanda Investigational Site
mi
from
Tulsa, OK
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Bexley, OH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Corning, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site 1
mi
from
Miami, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
Status: Enrolling, Phase III
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
Status: Enrolling, Phase III
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Doral, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
Status: Enrolling, Phase III
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Frisco, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
Status: Enrolling, Phase III
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
New Albany, IN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
Status: Enrolling, Phase III
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
Status: Enrolling, Phase III
Updated: 12/31/1969
Pace Dermatology Associates
mi
from
Lakewood, WA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
Status: Enrolling, Phase III
Updated: 12/31/1969
Midwest Allergy Sinus Asthma, SC ( Site 0081)
mi
from
Normal, IL
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
Status: Enrolling, Phase III
Updated: 12/31/1969
Owensboro Dermatology Associates
mi
from
Owensboro, KY
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
Status: Enrolling, Phase III
Updated: 12/31/1969
Mosaic Dermatology
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
Status: Enrolling, Phase III
Updated: 12/31/1969
Dermatology Associates of Seattle
mi
from
Seattle, WA
Click here to add this to my saved trials
Alopecia Areata Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Skin Care Physicians of Georgia
mi
from
Macon, GA
Click here to add this to my saved trials
Alopecia Areata Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Utah MidValley Dematology
mi
from
Murray, UT
Click here to add this to my saved trials
Alopecia Areata Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Stanford Health Care
mi
from
Redwood City, CA
Click here to add this to my saved trials
Alopecia Areata Clinical Trial
A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Stephen L Miller, MD, PA
mi
from
San Antonio, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Institute of Skin Advancement Medical, Surgical, Costmetic & Laser Dermatology
mi
from
Calgary,
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
DermDox Centers for Dermatology
mi
from
Hazleton, PA
Click here to add this to my saved trials
Common Wart Clinical Trial
Study of A-101 Topical Solution for the Treatment of Common Warts
Status: Enrolling, Phase III
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Common Wart Clinical Trial
Study of A-101 Topical Solution for the Treatment of Common Warts
Status: Enrolling, Phase III
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Common Wart Clinical Trial
Study of A-101 Topical Solution for the Treatment of Common Warts
Status: Enrolling, Phase III
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Verona, NJ
Click here to add this to my saved trials
Common Wart Clinical Trial
Study of A-101 Topical Solution for the Treatment of Common Warts
Status: Enrolling, Phase III
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Warren, MI
Click here to add this to my saved trials
Keratoconus Clinical Trial
Custom Anterior Surfacing of Scleral Lens for Vision Quality Improvement in Patients With Keratoconus
Status: Enrolling
Updated: 12/31/1969
Flaum Eye Institute, University of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study Comparing Two Topicals in the Treatment of Acne Vulgaris
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Jonathan Corren MD, Inc.
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Vital Prospects Clinical Research Institute PC - CRN
mi
from
Tulsa, OK
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4
Status: Enrolling, Phase I
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Doral, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4
Status: Enrolling, Phase I
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Anderson, SC
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Northridge, CA
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Academic Centers Research and Education
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Olympian Clinical Research
mi
from
Largo, FL
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Research Center, Inc. - Los Alamitos Site
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
Chronic Spontaneous Urticaria Clinical Trial
A Phase III Study of Efficacy and Safety of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Acne Vulgaris Clinical Trial
A Study of the Safety, Engraftment, and Action of Multi-Dosed NB01 in Adults With Moderate Acne
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
Alopecia Areata Clinical Trial
PF-06651600 for the Treatment of Alopecia Areata
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Siperstein Dermatology Group
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
2a Study to Assess the Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Forest Hills, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Piedmont Plastic Surgery and Dermatology
mi
from
Charlotte, NC
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Tien Q. Nguyen, MD inc. DBA First OC Dermatology
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Basal Cell Nevus Syndrome Clinical Trial
Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome
Status: Enrolling, Phase III
Updated: 12/31/1969
Hopital Saint-Louis
mi
from
Paris,
Click here to add this to my saved trials
Atopic Dermatitis Eczema Clinical Trial
Study in Subjects With Moderate Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Ralexar Investigational Site 2
mi
from
San Antonio, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Henderson, NV
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.
Status: Enrolling, Phase II
Updated: 12/31/1969
LEO Pharma Investigational Site
mi
from
High Point, NC
Click here to add this to my saved trials
1 … 9 10 11 12 13 14 15 16 17 18 19 20 21